Phase 4
Completed N=100
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
Source: ClinicalTrials.gov NCT00828412 ↗Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcomePrimary: Change From Baseline in Three Item Severity Score — -2.6; -3.6 units on a scale
Summary
This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Three Item Severity Score |
-2.6; -3.6 | — |
Eligibility Criteria
Inclusion Criteria
- at least 3 months of age and less than 13 years of age
- atopic dermatitis of moderate severity
Exclusion Criteria
- pregnant or lactating
- treatment of atopic dermatitis with topical product in the 14 days prior to Baseline
- treatment of atopic dermatitis with systemic product in the 30 days prior to Baseline
- serious or uncontrolled medical condition
- active infection
- significant use of inhaled, intranasal, or intraocular corticosteroid
Data sourced from ClinicalTrials.gov (NCT00828412). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.